Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Editor’s note: Progress and Promise Against Cancer is the AACR’s initiative to educate the public about cancer and cancer...
As a monthly feature on this blog, we spotlight the 10 articles selected by our editors from each journal...
Today, September 24, 2018, is World Cancer Research Day. The American Association for Cancer Research (AACR) is proud to...
Cancer treatments have been, and continue to be in most cases, based on the organ site where the tumor...
In 2017, electronic cigarettes (e-cigarettes) were the most commonly used tobacco product among high and middle school students. Many...
The past month has seen the U.S. Food and Drug Administration (FDA) expand the use of four anticancer therapeutics,...
Today, the American Association for Cancer Research (AACR) released its eighth annual Cancer Progress Report. The report highlights how...
Building upon the success of the African Cancer Researchers Travel Awards, the American Association for Cancer Research is pleased...
As a predoctoral student in the Integrated Biomedical Sciences Graduate Program at The Ohio State University in 2005, Bethany...
Immuno-oncology has revolutionized treatment for certain types of cancers, but currently it is only effective for about 20 percent...